| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-induced EMT: mechanisms and implications for fibrotic lung disease
1 Heart and Lung Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
2 Medicine, University of Southern California, Los Angeles, California, United States
* To whom correspondence should be addressed. E-mail: zborok{at}usc.edu.
"Epithelial-mesenchymal transition" (EMT), a process whereby fully differentiated epithelial cells undergo transition to a mesenchymal phenotype giving rise to fibroblasts and myofibroblasts, is increasingly recognized as playing an important role in repair and scar formation following epithelial injury. The extent to which this process contributes to fibrosis following injury in the lung is a subject of active investigation. Recently, it was demonstrated that TGF-
induces EMT in alveolar epithelial cells (AEC) in vitro and in vivo, and epithelial and mesenchymal markers have been co-localized to hyperplastic type II (AT2) cells in lung tissue from patients with idiopathic pulmonary fibrosis (IPF), suggesting that AEC may exhibit extreme plasticity and serve as a source of fibroblasts and/or myofibroblasts in lung fibrosis. In this review, we describe the characteristic features of EMT and its mechanistic underpinnings. We further describe the contribution of EMT to fibrosis in adult tissues following injury, focusing especially on the critical role of TGF- and its downstream mediators in this process. Finally, we highlight recent descriptions of EMT in the lung, and the potential implications of this process for the treatment of fibrotic lung disease. Treatment for fibrosis of the lung in diseases such as IPF has heretofore focused largely on amelioration of potential inciting processes such as inflammation. It is hoped that this review will stimulate further consideration of the cellular mechanisms of fibrogenesis in the lung and especially the role of the epithelium in this process, potentially leading to innovative avenues of investigation and treatment.
This article has been cited by other articles:
|
|
 |
|
  R. C. Chambers Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling Eur. Respir. Rev., December 1, 2008; 17(109): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Herzog, A. R. Brody, T. V. Colby, R. Mason, and M. C. Williams Knowns and Unknowns of the Alveolus Proceedings of the ATS, September 15, 2008; 5(7): 778 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Stevens, S. Phan, M. G. Frid, D. Alvarez, E. Herzog, and K. R. Stenmark Lung Vascular Cell Heterogeneity: Endothelium, Smooth Muscle, and Fibroblasts Proceedings of the ATS, September 15, 2008; 5(7): 783 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Strutz The great escape--myofibroblasts in fibrosis and the immune system Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2477 - 2479. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop Stem Cells and Cell Therapies in Lung Biology and Lung Diseases Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ivanova, M. J. Butt, and D. G. Matsell Mesenchymal transition in kidney collecting duct epithelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1238 - F1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kisseleva and D. A. Brenner Fibrogenesis of Parenchymal Organs Proceedings of the ATS, April 15, 2008; 5(3): 338 - 342. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
